Remdesivir plus dexamethasone is associated to improve the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status

INTRODUCTION: Remdesivir seems to reduce the risk of hospitalization and improve clinical outcome in hospitalized patients with COVID-19. OBJECTIVES: To compare the clinical outcome of COVID-19 hospitalized patients treated with remdesivir plus dexamethasone versus dexamethasone alone, according to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernal, Enrique, García-Villalba, Eva, Pons, Eduardo, Hernández, Maria Dolores, Báguena, Carlos, Puche, Gabriel, Carter, Paula, Martinez, Mónica, Alcaraz, Antonia, Tomás, Cristina, Muñoz, Angeles, Vicente, Maria Rosario, Nuñez, Maria Luz, Sancho, Natalia, Villalba, Mari Carmen, Cano, Alfredo, Minguela, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073576/
https://www.ncbi.nlm.nih.gov/pubmed/37100681
http://dx.doi.org/10.1016/j.medcli.2023.03.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073576/
https://www.ncbi.nlm.nih.gov/pubmed/37100681
http://dx.doi.org/10.1016/j.medcli.2023.03.025

Ejemplares similares